Facilitators and barriers to care among individuals with osteogenesis imperfecta
Selena Guo(Baylor College of Medicine), Eric A. Storch(Baylor College of Medicine), Marie‐Eve Robinson(University of Ottawa), Julia Morales(Baylor College of Medicine), Kara Ayers(GC Systems (United States)), Francesca Gedeon(Baylor College of Medicine), Whitney S. Shepherd(Baylor College of Medicine), Brendan Lee(Baylor College of Medicine), Kristin M. Kostick(Baylor College of Medicine), Chaya N. Murali(Baylor College of Medicine), Andrew D. Wiese(Baylor College of Medicine), V. Reid Sutton(Baylor College of Medicine), W. Conor Rork(Columbia College), Hannah Cho(Baylor College of Medicine), Dianne Nguyen(Baylor College of Medicine), Gianna M. Colombo(Baylor College of Medicine), Justin H. Qian(Baylor College of Medicine), Sophie C. Schneider(Baylor College of Medicine)
Cited by 0
Related Papers
IRF2BPL Is Associated with Neurological Phenotypes
|The American Journal of Human Genetics|2018|115
MicroRNA miR-23a cluster promotes osteocyte differentiation by regulating TGF-β signalling in osteoblasts
|Nature Communications|2017|96
Phenylbutyrate therapy for maple syrup urine disease
|Human Molecular Genetics|2010|94
Expanding the Spectrum of BAF-Related Disorders: De Novo Variants in SMARCC2 Cause a Syndrome with Intellectual Disability and Developmental Delay
|The American Journal of Human Genetics|2018|91
De Novo Truncating Variants in ASXL2 Are Associated with a Unique and Recognizable Clinical Phenotype
|The American Journal of Human Genetics|2016|87